Suzhou Ribo Life Science develops nucleic acid drugs and related products based on the RNA interference technology. Founded by Zicai Liang in 2007, Suzhou Ribo Life Science is backed by investors that include China State-Owned Capital Venture Investment Fund, CICC, Everest Ventures, Hillhouse Capital Group, and SAIC Capital and is headquartered in Kunshan.